ArticleFrontiers in aging neuroscience2024

Golexanolone reduces glial activation in the striatum and improves non-motor and some motor alterations in a rat model of Parkinson's disease.

Paula Izquierdo-Altarejos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.